These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 24252694)
1. Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain. Calvert AE; Dixon KL; Delorey MJ; Blair CD; Roehrig JT Vaccine; 2014 Jan; 32(2):258-64. PubMed ID: 24252694 [TBL] [Abstract][Full Text] [Related]
2. Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area. Turtle L; Tatullo F; Bali T; Ravi V; Soni M; Chan S; Chib S; Venkataswamy MM; Fadnis P; Yaïch M; Fernandez S; Klenerman P; Satchidanandam V; Solomon T PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005263. PubMed ID: 28135273 [TBL] [Abstract][Full Text] [Related]
3. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain). Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162 [TBL] [Abstract][Full Text] [Related]
4. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice. Gromowski GD; Firestone CY; Whitehead SS J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo. Yun SI; Song BH; Polejaeva IA; Davies CJ; White KL; Lee YM J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826 [TBL] [Abstract][Full Text] [Related]
6. Enhanced Immune Responses Against Japanese Encephalitis Virus Infection Using Japanese Encephalitis Live-Attenuated Virus Adjuvanted with Montanide GEL 01 ST in Mice. Xu Y; Wang Q; Wei B; Huang X; Wen Y; Yan Q; Ma X; Zhao Q; Cao S; Huang Y; Wen X; Han X; Bai Y; Wu R Vector Borne Zoonotic Dis; 2019 Nov; 19(11):835-843. PubMed ID: 31314706 [TBL] [Abstract][Full Text] [Related]
7. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans. Song BH; Yun GN; Kim JK; Yun SI; Lee YM J Microbiol; 2012 Aug; 50(4):698-706. PubMed ID: 22923123 [TBL] [Abstract][Full Text] [Related]
8. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice. Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483 [TBL] [Abstract][Full Text] [Related]
9. T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine. Wang R; Zhen Z; Turtle L; Hou B; Li Y; Wu N; Gao N; Fan D; Chen H; An J Appl Microbiol Biotechnol; 2020 Aug; 104(15):6779-6789. PubMed ID: 32556415 [TBL] [Abstract][Full Text] [Related]
10. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice. Wei J; Wang X; Zhang J; Guo S; Pang L; Shi K; Liu K; Shao D; Qiu Y; Liu L; Widén F; Li B; Ma Z PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007601. PubMed ID: 31374086 [TBL] [Abstract][Full Text] [Related]
11. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China. Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360 [TBL] [Abstract][Full Text] [Related]
13. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection. Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Yu Y Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891 [TBL] [Abstract][Full Text] [Related]
15. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І. Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X Virol J; 2015 Dec; 12():214. PubMed ID: 26651827 [TBL] [Abstract][Full Text] [Related]
16. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China. Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278 [TBL] [Abstract][Full Text] [Related]
17. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice. Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443 [TBL] [Abstract][Full Text] [Related]
18. [Progress in the research of phenotype and genotype of Japanese encephalitis virus in China]. Chen N; Yu YX Bing Du Xue Bao; 2013 Jun; 29(4):457-64. PubMed ID: 23895014 [TBL] [Abstract][Full Text] [Related]
19. Japanese encephalitis: the virus and vaccines. Yun SI; Lee YM Hum Vaccin Immunother; 2014; 10(2):263-79. PubMed ID: 24161909 [TBL] [Abstract][Full Text] [Related]
20. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). Fischer M; Lindsey N; Staples JE; Hills S; MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]